The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
VJVirtual | New therapies for MPNs
Jean-Jacques Kiladjian, MD, PhD, Saint-Louis Hospital & Paris Diderot University, Paris, France, explores emerging therapies for patients with myelofibrosis including pacritinib and momelotinib, JAK kinase inhibitors, as well as other agents therapies being investigated as single agents or as part of combined approaches. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
